Close
Nordic 9Nordic 9

Sequential Skin (private company)

United Kingdom sequential.bio
See something wrong or missing? Let us know
Offices:London, Singapore
Industry:BiotechEcommerceHealth servicesPharma
Business model:B2B

Sequential Skin is a British biotech company founded by Albert Dashi and Oliver Worsley and using genomics and the skin's microbiome to identify the best skin products suited for individuals

Investors: we tracked 8 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 5.65M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Sequential Skin

Name Criteria
France PEP-Therapy
77%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
United Kingdom CardiaTec Biosciences
77%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Carcinotech
77%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 5M - 10M USD
Sweden Atley Solutions
73%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 5
  • Total raised in a similar range: 5M - 10M USD
Sweden Cinclus Pharma
72%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 3
Denmark Octarine Bio
72%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 3
United Kingdom Causaly
72%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 2
Italy Kither Biotech
72%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 3
United Kingdom Epitopea
72%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 5
United Kingdom Mable
72%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 2
Top